You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Minimal Residual Disease monitoring

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Using Mass Spectrometry Detecting Minimal Residual Disease in

Recruiting
  • Multiple Myeloma
    • Tianjin, China
      InsituteHBDH
    Sep 8, 2022

    Minimal Residual Disease, Esophageal Squamous Cell Carcinoma Trial in Guangzhou

    Not yet recruiting
    • Minimal Residual Disease
    • Esophageal Squamous Cell Carcinoma
      • Guangzhou, Guangdong, China
        Guangdong Provincial People's Hospital
      Jun 10, 2023

      Minimal Residual Disease in Gastric Cancer by Liquid Biopsy

      Recruiting
      • Gastric Cancer
      • ctDNA
      • ctDNA
      • Ho Chi Minh City, Vietnam
        University Medical Center Ho Chi Minh City
      Apr 27, 2022

      First-Line Serplulimab Plus Chemotherapy in Treatment of

      Not yet recruiting
      • Lung Cancer
      • Serplulimab plus chemotherapy
      • (no location specified)
      May 16, 2023

      Minimal Residual Disease of Acute Myelogenous Leukemia or High

      Recruiting
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndrome
        • Rochester, New York
          University of Rochester Medical Center
        May 3, 2022

        Breast Cancer Trial (Giredestrant, Abemaciclib, Inavolisib)

        Not yet recruiting
        • Breast Cancer
        • (no location specified)
        Feb 1, 2023

        ctDNA Methylation Sequencing for Myeloma

        Recruiting
        • Multiple Myeloma
        • plasma circulation DNA methylation sequencing
        • Tianjin, China
          Institute of Hematology and Blood Diseases Hospital Chinese Acad
        Oct 11, 2022

        Acute Lymphocytic Leukemia, Adult B-Cell, BCR-ABL1 Fusion Protein Expression Trial in Nanjing (Flumatinib)

        Recruiting
        • Acute Lymphocytic Leukemia, Adult B-Cell
        • BCR-ABL1 Fusion Protein Expression
        • Nanjing, Jiangsu, China
        • +1 more
        Mar 22, 2022

        Hepatocellular Carcinoma Recurrence After Curative Treatment by

        Recruiting
        • Hepatocellular Carcinoma Resectable
        • circulating tumor DNA
        • Foshan, Guangdong, China
        • +5 more
        Nov 27, 2023

        Minimal Residual Disease(MRD)in Pediatric B-acute Lymphoblastic

        Recruiting
        • B Acute Lymphoblastic Leukemia
        • Minimal residual disease (MRD) monitoring
        • Guangzhou, Guangdong, China
          Sun Yat-sen University Cancer Center
        Jul 25, 2021

        MRD-tailored Therapy in Newly Diagnosed Multiple Myeloma With

        Not yet recruiting
        • Multiple Myeloma
        • Minimal Residual Disease
          • (no location specified)
          Nov 1, 2023

          Minimal Residual Disease Using Multi-omics Approach

          Not yet recruiting
          • Pancreatic Ductal Adenocarcinoma
          • Blood collection and Pancreatic ductal adenocarcinoma minimal residual disease detection test
          • Shanghai, China
            Department of Pancreatic and Hepatobiliary Surgery, Fudan Univer
          Nov 29, 2023

          Minimally Residual of Esophageal Cancer 001

          Recruiting
          • Esophageal Carcinoma
          • Minimal Residual Disease
            • Shijiazhuang, Hebei, China
              Fourth Hospital of Hebei Medical University
            Jul 17, 2023

            Minimal Residual Disease in Peripheral T-cell Lymphoma

            Active, not recruiting
            • Peripheral T Cell Lymphoma
            • Tumor biopsy
            • +2 more
            • Boston, Massachusetts
            • +2 more
            Dec 19, 2022

            MRD and Clonal Evolution in Waldenström's Macroglobulinemia and

            Active, not recruiting
            • Waldenstrom Macroglobulinemia
            • MRD and clonal evolution
            • Milano, MI, Italy
            • +13 more
            Nov 2, 2022

            B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)

            Recruiting
            • B-Cell Lymphoblastic Leukemia
            • Acute Lymphoblastic Leukemia
            • Tampa, Florida
              Moffitt Cancer Center
            Nov 28, 2023

            GUIDING MULTI-MODAL THERAPIES AGAINST MINIMAL RESIDUAL DISEASE

            Enrolling by invitation
            • Pancreatic Adenocarcinoma
            • liquid biopsy
            • Stockholm, Sweden
              Gastrocentrum, KarolinskaUniversity Hospital
            Oct 26, 2023

            Next-generation Sequencing in Pediatric B-ALL Children Patients

            Not yet recruiting
            • Acute Lymphoblastic Leukemia, Pediatric
            • (no location specified)
            Apr 19, 2023

            Minimal Residual Disease Trial in Tianjin (QN-030a, Cyclophosphamid, Fludarabine)

            Recruiting
            • Minimal Residual Disease
            • Tianjin, Tianjin, China
              Institute of Hematology & Blood Diseases Hospital
            Nov 3, 2022

            Multiple Myeloma Trial (Dexamethasone, Isatuximab, Lenalidomide)

            Not yet recruiting
            • Multiple Myeloma
            • (no location specified)
            Jan 10, 2023

            AML, Adult, Minimal Residual Disease Trial (MRD assessment)

            Not yet recruiting
            • AML, Adult
            • Minimal Residual Disease
            • MRD assessment
            • (no location specified)
            Oct 13, 2023

            Rectal Cancer Patients Based on ctDNA-MRD Technology

            Recruiting
            • Rectal Adenocarcinoma
            • +3 more
            • MRD detection
            • Guangzhou, Guangdong, China
              WeiWei Xiao
            Jul 31, 2023

            Stage II-III Gastric Cancer Trial in Jinan, Qingdao, Yantai (MRD-guided therapy)

            Recruiting
            • Stage II-III Gastric Cancer
            • MRD-guided therapy
            • Jinan, Shandong, China
            • +4 more
            Nov 27, 2023

            Danish Assessment of Minimal Residual Disease by Liquid Biopsies

            Recruiting
            • Colorectal Neoplasms
            • +5 more
              • Copenhagen, Capital Region Of Denmark, Denmark
              • +8 more
              Oct 13, 2023

              Novel Digital Array PCR for Acute Myeloid Leukemia (AML)

              Recruiting
              • Leukemia, Myeloid, Acute
              • Minimal Residual Disease
                • Chapel Hill, North Carolina
                  North Carolina Cancer Hospital (NCCH)
                Feb 2, 2023